Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05456165
Title Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gritstone bio, Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
NYU Langone Health New York New York 10016 United States Details
Christ Hospital Cancer Center Cincinnati Ohio 45229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field